SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-010303
Filing Date
2024-03-18
Accepted
2024-03-18 16:05:37
Documents
35
Period of Report
2024-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40722
2 ex99-1.htm EX-99.1 76956
3 ex99-2.htm EX-99.2 16501
4 ex99-1_001.jpg GRAPHIC 12455
5 ex99-2_001.jpg GRAPHIC 179561
6 ex99-2_002.jpg GRAPHIC 761287
7 ex99-2_003.jpg GRAPHIC 307845
8 ex99-2_004.jpg GRAPHIC 261966
9 ex99-2_005.jpg GRAPHIC 296033
10 ex99-2_006.jpg GRAPHIC 315994
11 ex99-2_007.jpg GRAPHIC 327504
12 ex99-2_008.jpg GRAPHIC 237720
13 ex99-2_009.jpg GRAPHIC 133269
14 ex99-2_010.jpg GRAPHIC 138587
15 ex99-2_011.jpg GRAPHIC 415742
16 ex99-2_012.jpg GRAPHIC 337863
17 ex99-2_013.jpg GRAPHIC 337053
18 ex99-2_014.jpg GRAPHIC 399100
19 ex99-2_015.jpg GRAPHIC 365212
20 ex99-2_016.jpg GRAPHIC 267342
21 ex99-2_017.jpg GRAPHIC 348973
22 ex99-2_018.jpg GRAPHIC 305880
23 ex99-2_019.jpg GRAPHIC 127320
  Complete submission text file 0001493152-24-010303.txt   8420608

Data Files

Seq Description Document Type Size
24 XBRL SCHEMA FILE ltrn-20240318.xsd EX-101.SCH 3030
25 XBRL LABEL FILE ltrn-20240318_lab.xml EX-101.LAB 34240
26 XBRL PRESENTATION FILE ltrn-20240318_pre.xml EX-101.PRE 22369
38 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3761
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 24759000
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)